7 Nov - 7 Nov '18

VCA Meeting_VCA: A new field has matured

7 November, 2018
The VCA (Vascularized Composite Allotransplantation) section of the ESOT is proud to announce for 2018 a brand new appointment for the Vascularized

VCA Meeting_VCA: A new field has matured

Start Date:
Wednesday, 7th November, 2018 at 2:00pm
End Date:
Wednesday, 7th November, 2018 at 5:00pm
Important Dates:
*** Online Registrations open***

The VCA Meeting is held during the TLJ (Transplantation Learning Journey) Week. 

Click here to learn more about TLJ2018 and the educational opportunities.
Country: Germany
Description & Objectives:

7 November, 2018

The VCA (Vascularized Composite Allotransplantation) section of the ESOT is proud to announce for 2018 a brand new appointment for the Vascularized and Composite Allotransplantation Community.

This fresh new meeting will be dedicated to foster scientific and clinical developments in Europe in the field and aims to serve as a platform for scientists and clinicians for information exchange.

Specifically we will provide an update on the progress made in the field of VCA over the past two decades and highlight latest clinical developments. We will share insights and lessons learned from successful VCA programs on how to establish programs and embark on this specific type of transplants. In addition, long term outcomes and features of chronic rejection as recently observed in VCA will be discussed. Finally, we will provide an overview of hot topics in basic and translational research related to VCA as well as an outlook of novel technologies on the horizon to further advance this exciting area in transplantation.

 

>>>>** Download the VCA2018 Scientific Programme**

>>>>**Download the VCA2018 Second Announcement Flyer (PDF)**

 

Main Topics

• Establishing a successful VCA program: insights and lessions learned.

• Chronic rejection and long-term outcomes in VCA.

• What’s hot What’s new in basic and tranlational research related to VCA.

Educational Objectives

After attending this meeting, participants will be able to:

• Understand indications and contra indications, team composition, logistical requirements to establish a VCA program.

• Evaluate outcomes after VCA.

• Gain insight into the pathophysiology of chronic rejection in VCA and its clinical implications

• Obtain an overview of latest research developments in the field.

Target Group:

Transplant surgeons, plastic and reconstuctive surgeons, transplant coordinators, transplant nurses, organ procurement organization staff, basic scientists.